Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 17/20 | 0.43 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.38 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL964901 | 1.00 | EGLN1 (0.43) | EGLN1FTOBBOX1ADORA2AADORA1 | |
| SCHEMBL967119 | 0.92 | EGLN1 (0.45) | EGLN1FTOBBOX1ADORA2AADORA1 | |
| SCHEMBL966064 | 0.85 | EGLN1 (0.52) | EGLN1FTOBBOX1KDM5BKDM2A | |
| SCHEMBL969028 | 0.83 | EGLN1 (0.60) | EGLN1FTOBBOX1 | |
| SCHEMBL967989 | 0.83 | EGLN1 (0.44) | EGLN1FTOBBOX1KDM5BKDM2A | |
| SCHEMBL965224 | 0.81 | EGLN1 (0.45) | EGLN1FTOBBOX1ADORA2AADORA1 | |
| SCHEMBL969100 | 0.79 | EGLN1 (0.47) | EGLN1FTOBBOX1 | |
| SCHEMBL30274587 | 0.78 | EGLN1 (0.64) | EGLN1FTOBBOX1KDM5BKDM2A | |
| SCHEMBL968184 | 0.78 | EGLN1 (0.64) | EGLN1FTOBBOX1KDM5BKDM2A | |
| SCHEMBL967787 | 0.77 | EGLN1 (0.60) | EGLN1FTOBBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4142721-A1 | HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS FOR TREATING AGING-RELATED CONDITIONS | Bioage Labs, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |